Literature DB >> 12227974

Social network, social support and the rate of decline of CD4 lymphocytes in asymptomatic HIV-positive homosexual men.

Leif Persson1, Per-Olof Ostergren, Bertil S Hanson, Anna Lindgren, Anders Naucler.   

Abstract

AIMS: To test a stress-disease hypothesis by investigating the influence of social network and social support factors on the course over time of the CD4 lymphocytes in an HIV-positive population of gay men.
METHODS: The study is a prospective cohort study of a representative population of HIV-positive gay men, undertaken at the Department of Infectious Diseases, Malmö University Hospital. This is the only clinic providing care for HIV-positive individuals in the city of Malmö in southern Sweden (population 248,000). A total of 115 HIV-positive homosexual men, who had not received an AIDS diagnosis, were invited to take part in the study. Seventy-five men (65%) accepted to be interviewed and 64 men (56%) fulfilled the inclusion criteria for the statistical analysis.
RESULTS: In a multivariate analysis adjustments were made for age, level of the first CD4 count and time since first contact with the clinic. Men with high family contact frequency had a longer half-life (20.3 years) of the CD4 lymphocyte count than men with a low family contact frequency (7.4 years) (p = 0.03). Men with high social participation also had a longer half-life of CD4 lymphocyte count (14.7 years), compared with men with low social participation (6.3 years, p = 0.10).
CONCLUSIONS: The findings of this study imply the importance of social support and social network factors as modifiers of the rate of decline of the CD4 lymphocyte level, which is an important prognostic marker of survival in HIV-positive homosexual men.

Entities:  

Mesh:

Year:  2002        PMID: 12227974     DOI: 10.1080/14034940210133870

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  7 in total

1.  Neighborhood and Network Characteristics and the HIV Care Continuum among Gay, Bisexual, and Other Men Who Have Sex with Men.

Authors:  Hong-Van Tieu; Beryl A Koblin; Carl Latkin; Frank C Curriero; Emily R Greene; Andrew Rundle; Victoria Frye
Journal:  J Urban Health       Date:  2020-10       Impact factor: 3.671

2.  Depression, social support, and stigma as predictors of quality of life over time: results from an Asha-based HIV/AIDS intervention in India.

Authors:  Dana Rose Garfin; Sanghyuk S Shin; Maria L Ekstrand; Kartik Yadav; Catherine L Carpenter; Sanjeev Sinha; Adeline M Nyamathi
Journal:  AIDS Care       Date:  2019-02-03

3.  Main partner factors associated with worse adherence to HAART among women in Baltimore, Maryland: a preliminary study.

Authors:  Amy R Knowlton; Cui Yang; Amy Bohnert; Lawrence Wissow; Geetanjali Chander; Julia A Arnsten
Journal:  AIDS Care       Date:  2011-05-24

4.  Sources and types of social support that influence engagement in HIV care among Latinos and African Americans.

Authors:  Sheba George; Belinda Garth; Amy Rock Wohl; Frank H Galvan; Wendy Garland; Hector F Myers
Journal:  J Health Care Poor Underserved       Date:  2009-11

Review 5.  Analysis of social epidemiology research on infectious diseases: historical patterns and future opportunities.

Authors:  Justin M Cohen; Mark L Wilson; Allison E Aiello
Journal:  J Epidemiol Community Health       Date:  2007-12       Impact factor: 3.710

6.  Translation, Adaption, and Psychometric Testing of the Myanmar Version of the Medical Outcomes Study Social Support Survey for People Living With HIV/AIDS.

Authors:  Feifei Huang; Wei-Ti Chen; Sai Htun Lin; Min San Tun; Thet Wai Nwe; Yin Thet Nu Oo; Htun Nyunt Oo
Journal:  Front Psychol       Date:  2021-09-07

7.  Putting episodic disability into context: a qualitative study exploring factors that influence disability experienced by adults living with HIV/AIDS.

Authors:  Kelly K O'Brien; Aileen M Davis; Carol Strike; Nancy L Young; Ahmed M Bayoumi
Journal:  J Int AIDS Soc       Date:  2009-11-09       Impact factor: 5.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.